Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 15,559 |
| Marketable Securities | 546 |
| Other current assets | 386 |
| TOTAL | $16,491 |
| Non-Current Assets | |
| Other Non-Current Assets | 14 |
| TOTAL | $14 |
| Total Assets | $16,757 |
| Liabilities | |
| Current Liabilities | |
| Accounts payable and accrued liabilities | 259 |
| Accrued Expenses | 236 |
| TOTAL | $595 |
| Non-Current Liabilities | |
| Other Non-Current Liabilities | 19 |
| TOTAL | $19 |
| Total Liabilities | $776 |
| Shareholders' Equity | |
| Retained earnings | -30,531 |
| Other shareholders' equity | 43,904 |
| TOTAL | $15,981 |
| Total Liabilities And Equity | $16,757 |